Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Prognostic models for overall survival (OS) for patients with metastatic castration-resistant prostate cancer (mCRPC) are dated and do not reflect significant advances in treatment options available for these patients. This work developed and validated an updated prognostic model to predict...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Halabi, Susan, Lin, Chen-Yen, Kelly, W. Kevin, Fizazi, Karim S., Moul, Judd W., Kaplan, Ellen B., Morris, Michael J., Small, Eric J.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2014
Témata:
ORIGINAL REPORTS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3927736/
https://ncbi.nlm.nih.gov/pubmed/24449231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.52.3696
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky